drugset / Trial / NCT00633919
Efficacy of SLITone in House Dust Mite Allergic Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This trial has been designed to evaluate the efficacy of specific immunotherapy with SLITone Dermatophagoides mix compared with placebo in subjects with house dust mite allergic asthma, based on asthma medication use during a period of 2 months with a high environmental exposure to mites (autumn 2008).
Timeline
- Start
- 2006-07
- Primary completion
- 2008-12
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SLITone Dermatophagoides mix | Other / unclassified | 200 unknown | Subcutaneous |
| Comparator | Budesonide | Small molecule | 64 ug | Intranasal |
| Comparator | Budesonide/formoterol | Unknown | 4.5 ug | Inhaled |
| Comparator | Budesonide/formoterol | Unknown | 80 ug | Inhaled |
| Comparator | Desloratadine | Small molecule | 5 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | Oral |
| Comparator | Salbutamol | Unknown | 200 ug | Inhaled |